Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Chugai starts phase I clinical trials with phosphate binder

Dec. 4, 1996

Negative clinical results reported for aromatase inhibitor in BPH

Nov. 29, 1996

Kissei begins overseas development of BPH treatment agent

Nov. 21, 1996

Kyorin claims cholinergic agents

Nov. 21, 1996

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Nov. 19, 1996

OP-1 effective in renal failure

Nov. 15, 1996

Clinical trial program for RenaGel continues on schedule

Nov. 8, 1996

Synaptic, Merck extend BPH collaboration

Nov. 8, 1996

CV Therapeutics reports novel adenosine antagonist

Nov. 8, 1996

Potential use of phytopharmaceutical compounds for BPH

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...